Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Eli Lilly, Food and Drug Administration
US FDA approves Eli Lilly's drug for eczema
Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old.
Eli Lilly Invests $1.8B To Expand Drug Output in Ireland
Key Takeaways Eli Lilly is investing $1.8 billion to expand production in Ireland of its Alzheimer's treatment and weight-loss drugs.The company's Alzheimer's drug, Kisunla, was approved by the U.S. Food and Drug Administration last month.
Eli Lilly To Spend $1.8 Billion Expanding Drug Manufacturing
Pharmaceutical giant Eli Lilly (LLY) says it will spend $1.8 billion U.S. to expand its manufacturing capacity as it tries to meet global demand for its recently approved Alzheimer's drug and popular weight loss and diabetes medications.
Ethan Slater, Lilly Jay and Ariana Grande
Ariana Grande's Boyfriend Ethan Slater Finalizes Divorce from Lilly Jay
Ethan Slater and Lilly Jay, who share one child, have finalized their divorce with estranged wife Lilly Jay. Slater is currently dating Wicked costar Ariana Grande.
Ariana Grande's Boyfriend Ethan Slater is Officially Divorced
Ariana Grande's boyfriend Ethan Slater has reportedly finalized his divorce from ex-wife Lilly Jay. SportsYahoo Sports
Ethan Slater has settled his divorce from Lilly Jay
The actor and Ariana went public with their romance last October, three months after they split. The Broadway actor - who is now dating Ariana Grande - split from his high school sweetheart in summer 2023 amid claims he had grown close to his 'Wicked' co-star,
1d
on MSN
Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production
Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular ...
1d
6 Incredible Reasons to Invest in Eli Lilly
Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...
24/7 Wall St
1d
Eli Lilly (LLY) Stock Price Prediction and Forecast 2025-2030
Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 607.25% and ...
FierceBiotech
3d
Lilly delivers one-two punch with 2nd tranche of positive data on weekly insulin candidate
Shortly after a positive data drop for Eli Lilly’s efsitora a | Lilly revealed that its weekly insulin candidate efsitora ...
1d
Eli Lilly & Co. stock underperforms Friday when compared to competitors
Shares of Eli Lilly & Co. LLY shed 1.21% to $923.71 Friday, on what proved to be an all-around positive trading session for ...
3d
on MSN
Health Rounds: Once-weekly insulin from Eli Lilly appears effective as daily injections
Eli Lilly’s experimental insulin that is injected just once a week is as effective as daily insulin injections for ...
Yahoo Finance
5d
Lilly appoints insider as finance chief amid rising investments to boost capacity
(Reuters) - U.S. drugmaker Eli
Lilly
on Monday said it has appointed insider Lucas Montarce as its new chief financial officer, effective immediately, months after former CFO Anat Ashkenazi ...
2d
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
1d
on MSN
Ariana Grande's Boyfriend Ethan Slater Finalizes Divorce With Lilly Jay: Report
Ethan Slater and Lilly Jay are now legally divorced, TMZ reports. The couple separated last year, after which the Broadway ...
20h
Ariana Grande’s boyfriend Ethan Slater finalizes divorce with Lilly Jay
The romance between Ariana Grande and Ethan Slater can officially go to the next level, now that the latter’s divorce has ...
1d
FDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ireland
Ethan Slater
Ariana Grande
Alzheimer's disease
Feedback